Century Therapeutics (IPSC) Other Non Operating Income (2020 - 2026)
Century Therapeutics' (IPSC) quarterly Other Non Operating Income came in at $20000.0 in Q1 2026, up 152.63% year-on-year from $7916.7 in Q1 2025, and up 111.05% on a QoQ basis from -$181000.0 in Q4 2025.
Century Therapeutics (IPSC) Other Non Operating Income (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Other Non Operating Income data on file, last reported at $20000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 152.63% year-over-year to $20000.0 in Q1 2026; TTM through Mar 2026 was $49000.0, a 120.85% increase from a year earlier, with the FY2025 full-year figure at -$9000.0, up 95.19% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $20000.0, up from -$181000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for IPSC reached as high as $4.4 million in Q4 2022 and fell as low as -$435000.0 in Q4 2024.
- Historically, Other Non Operating Income has averaged $223588.2 across 5 years, with a median of -$12000.0 in 2024.
- Across the five-year window, Other Non Operating Income jumped 2593.82% in 2022 and plunged 3820.0% in 2023, its largest moves.
- Year by year, Other Non Operating Income stood at $4.4 million in 2022, then slumped by 100.34% to -$15000.0 in 2023, then sank by 2800.0% to -$435000.0 in 2024, then jumped by 58.39% to -$181000.0 in 2025, then soared by 111.05% to $20000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $20000.0 in Q1 2026, -$181000.0 in Q4 2025, and $97000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | -181,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Dec 31, 2024 | -435,000.00 |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | -186,000.00 |
| Mar 31, 2023 | -194,000.00 |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | -24,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -61,000.00 |
| Dec 31, 2021 | -178,000.00 |
| Sep 30, 2021 | 140,000.00 |
| Jun 30, 2021 | -252,000.00 |